Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
BioAdvance Capital is an evergreen fund based in Conshohocken, Pennsylvania, dedicated to supporting early-stage life-science companies. The firm primarily invests in the Mid-Atlantic region of the United States, particularly along the I-95 corridor from New York City to Washington, D.C. They have backed over 120 companies and focus on improving human health through strategic funding.
BioAdvance Capital invests $500K to $1M in seed and Series A opportunities within the life sciences sector. Their investment focus includes biotech, healthcare, digital health, medical devices, and diagnostics. The firm aims to help companies achieve critical milestones that attract larger venture capital investments.
Notable companies in BioAdvance Capital's portfolio include Accelerated Biosciences, Acuity Pharmaceuticals, Allevi, Annovis, Avid Radiopharmaceuticals, ImmunoGenesis, Oncora Medical, Relmada Therapeutics, and Venatorx Pharmaceuticals. These companies have collectively raised over $4.4 billion in follow-on funding.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.